Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis
**Background:** Targeted therapy for cancer is becoming more frequent as the understanding of the molecular pathogenesis increases. Molecular testing must be done to use targeted therapy. Unfortunately, the testing turnaround time can delay the initiation of targeted therapy. **Objective:** To inve...
Saved in:
Main Authors: | Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith, Rhodri Saunders |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2023-06-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.77686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sternal-Wound Infections following Coronary Artery Bypass Graft: Could Implementing Value-Based Purchasing be Beneficial?
by: Dominique Brandt, et al.
Published: (2020-08-01) -
FastContext: A tool for identification of adapters and other sequence patterns in next generation sequencing (NGS) data
by: E. Viesná, et al.
Published: (2023-01-01) -
Pituitary Metastatic Composite Tumors: A Case Report with Next-Generation Sequencing and Review of the Literature
by: Matthew Helton, et al.
Published: (2020-01-01) -
Validation of a Model Estimating the Budget Impact of Video Capsule Endoscopy for Surveillance of Crohn’s Disease in an Italian Center
by: Rhodri Saunders, et al.
Published: (2024-03-01) -
Latest Approved Therapies for Metastatic Melanoma: What Comes Next?
by: Farid Menaa
Published: (2013-01-01)